Hospital Quiron Barcelona
Hospital Quiron Barcelona
Spain, Barcelona
Antonio Alcaraz
38 years of experience
Clinic is certified :
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Radiation Therapy for Sarcomas | from $3,250 | from $18,000 | from $8,000 |
| Proton-beam therapy | from $70,000 | from $80,000 | from $25,775 |
| Proton therapy for prostate cancer | from $30,000 | from $80,000 | from $70,000 |
| Proton therapy for breast cancer | from $30,000 | from $55,000 | from $85,000 |
The doctor is a distinguished medical oncologist with over 30 years of experience, specializing in the non-surgical treatment of genitourinary cancers, including prostate, kidney, and bladder cancers, as well as sarcomas and tumors of unknown origin. Currently, the doctor leads the Genitourinary, Central Nervous System, Sarcoma, and Unknown Origin Tumors Unit at Vall d'Hebron University Hospital in Barcelona and is affiliated with the Teknon Medical Center.
With a Ph.D. in Medicine and Surgery, the doctor has led numerous national multicenter clinical trials and has authored over 120 peer-reviewed articles. The doctor is recognized as one of Spain's leading experts in genitourinary oncology.
The doctor heads the Department of Urology and kidney transplantation at Teknon Medical Center in Barcelona, Spain, with over 30 years of experience. Specializing in uro-oncology and transplantology, the doctor has overseen more than 500 successful operations, focusing on pathologies of the urogenital system using minimally invasive methods, including laparoscopic and robotic-assisted surgeries.
The doctor is particularly noted for expertise in prostate cancer treatment and utilizes the Da Vinci robotic system for innovative surgical procedures. Additionally, the doctor treats congenital pathologies in children such as cryptorchism and is a member of the American Urological Confederation, Urological Association of Spain, and European Urological Society.
The doctor is an experienced oncologist recognized for successful breast cancer treatments. He holds an MBBS from University Autónoma de Barcelona and completed his residency at Clinic Vall d'Hebron. He conducted significant research on telomerase in New York.
He is the head of the breast cancer program at HM Delfos and leads Oncology services at Clin del Mar in Spain. As the director of the cancer research program at Del Mar, he is a prominent member of GEICAM, CIBERONC, AIECA, and SEOM. The doctor has published 120 articles in reputable journals, amassing over 9000 citations.